James Polston PhD is currently the Chief Science Officer of Helius Therapeutics in Auckland, New Zealand. He has previously worked in senior management positions for both Curaleaf and Trulieve, two of the largest medical cannabis providers in the world.
Dr. Polston holds advanced degrees in Neuroscience and Medical Ethics, and has ongoing research in the field of cannabis medicine.
Having published with the Director of the National Institute on Drug Abuse, Dr. Polston is knowledgeable in several areas of basic and clinical research. He is also an expert in plant-based therapeutics, after spending more than a decade investigating several possible treatments.
Visit the Helius Therapeutics website.
